Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$Gossamer Bio(GOSS.US)$        Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in Pah, Ph-Ild & Other Indications
Gossamer Bio Inc: Eligible to Receive up to $146 Mln in Regulatory and $180 Mln in Sales Milestones
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
1
1
+0
12
Translate
Report
4081 Views
Comment
Sign in to post a comment

View more comments...

2058Followers
31Following
25KVisitors
Follow